EFPIA - NEWSLETTER

EFPIA Newsletter 27 February 2020

European pharmaceutical industry response to coronavirus

As the impact of COVID-19 continues to be felt across the world, including recent deaths in Italy and France, the biopharmaceutical industry in Europe remains committed to global efforts to care for those affected, contain the outbreak and develop resources to tackle future outbreaks.

EFPIA members are heavily engaged in the IMI to fast track collaborative research, identifying any suitable assets in their libraries that could be utilised to develop diagnostics and treatments in the fight against COVID-19. In addition, the industry in Europe is providing financial support and in-kind donations to organisations on the ground as well as working closely with European, Chinese, and Global health authorities to combat this global public health emergency.

#WeWontRest until treatments for rare conditions become less rare

30 million Europeans live with a rare disease: that is 1 in 17 people. Through continued research & innovation, #WeWontRest until treatments for rare conditions become less rare.

Videos

Illness never sleeps #WeWontRest

Illness never sleeps. When everyone else is having 40 winks, illness is running round the block. Illness never sleeps, and medical innovation needs to be one step ahead, so that breakthroughs can be made. We won't rest until we've helped make the world a healthier place for everyone. Find out more at efpia.eu.

#WeWontRest until we make rare disease even rarer

Rare diseases are far more common than you might think, but treatments are rare. #WeWontRest until no one is left behind and no one will need to tackle rare diseases alone.

Events

16 MAR 2020

POSTPONED - China/EU Pharmaceutical Industry Forum 2020 Wavre, Belgium

** Event postponed until Autumn 2020 **

Learn more →

29 JUN 2020

DIA Europe 2020 Virtual Conference

As a direct result of the outbreak of the coronavirus disease (COVID-19), DIA has decided to postpone DIA Europe 2020...

Learn more →

31 MAR 2020

Clinical Trial Regulation Information Day for CEE Countries Warsaw, Poland

Are Central and Eastern European Union member states ready to implement the new EU Clinical Trial Regulation (536/2014)?...

Learn more →

26 OCT 2020

NEW DATES - EU Health Summit 2020 Virtual event

The EU Health Coalition is delighted to announce the second edition of the EU Health Summit.

Learn more →

What we are reading

Industry groups play down Coronavirus’ immediate risk to medicine supplies 25 February 2020 (ThePharmaLetter)

Making a difference for people living with rare diseases 10 February 2020 (Parliament Magazine)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶